<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01964417</url>
  </required_header>
  <id_info>
    <org_study_id>PEG-0488</org_study_id>
    <nct_id>NCT01964417</nct_id>
  </id_info>
  <brief_title>The Comparative Study Between Bowel Preparation Method</brief_title>
  <acronym>CSBPM</acronym>
  <official_title>The Comparative Study Between Bowel Preparation Method: 4L-split Dose of PEG Solution, Low-volume PEG Plus Ascorbic Acid Focusing on the Bowel Cleansing Efficacy, Patients' Affinity to Preparation Solution and Mucosal Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy, acceptability and preparation-induced
      mucosal inflammation of PEG + ascorbic acid vs. PEG for colonoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was a prospective randomized single-blinded clinical trial of ambulatory patients to
      assess the efficacy of bowel preparation and preparation-induced mucosal inflammation.

      Endoscopists who were blinded to the preparation taken, assessed both bowel cleansing by
      using the Ottawa bowel preparation assessment tool and preparation-induced mucosal
      inflammation. Acceptability was assessed by questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of colon cleansing between the two solutions using Ottawa scale</measure>
    <time_frame>3month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">319</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>4L-split Dose of PEG Solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4L-split Dose of PEG Solution for bowel preparation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-volume PEG Plus Ascorbic Acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low-volume PEG Plus Ascorbic Acid for bowel preparation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colonoscopy after bowel cleansing</intervention_name>
    <arm_group_label>4L-split Dose of PEG Solution</arm_group_label>
    <arm_group_label>Low-volume PEG Plus Ascorbic Acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who want colonoscopy purposing screening among adults between the age of
             20~65

        Exclusion Criteria:

          -  Under the age of 20, older than 65, pregnant or lactating women, intestinal
             obstruction, structural intestinal disease, hypothyroidism, gastrointestinal motility,
             renal failure, congestive heart failure, liver failure, electrolyte abnormalities, who
             refused research informed consent, inflammatory bowel disease, the obvious symptoms of
             the disease in patients with lower gastrointestinal (bloody stools, diarrhea, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jongha Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haeundae Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>612-896</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2013</study_first_submitted>
  <study_first_submitted_qc>October 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2013</study_first_posted>
  <last_update_submitted>January 9, 2014</last_update_submitted>
  <last_update_submitted_qc>January 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Jongha Park</investigator_full_name>
    <investigator_title>Inje University</investigator_title>
  </responsible_party>
  <keyword>BOWEL PREPARATION</keyword>
  <keyword>PEG</keyword>
  <keyword>Low-volume PEG Plus Ascorbic Acid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

